RTW Investments Overview

  • Investor Type

  • Hedge Fund

  • Status

  • Active

  • Professionals

  • 12

Professionals
  • Investments

  • 97

  • Portfolio

  • 35

  • Exits

  • 53

Exits

RTW Investments General Information

Description

Founded in 2009, RTW Investments is a hedge fund manager headquartered in New York, New York. The firm primarily focuses on a sector-oriented strategy focusing on life sciences, big data, and digital health sectors across the United States and Europe.

Contact Information

Website
www.rtwfunds.com
Year Founded
2009
Investor Status
Actively Seeking New Investments
Primary Investor Type
Hedge Fund
Other Investor Types
Venture Capital
Primary Office
  • 40 10th Avenue
  • Floor 7
  • New York, NY 10014
  • United States
+1 (646) 000-0000

RTW Investments Investments (97)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Abdera Therapeutics 04-Apr-2023 Early Stage VC 00000 Drug Discovery Pre-Clinical Trials
000000000 00000000 28-Mar-2023 0000 000.00 Pharmaceuticals Generating Revenue
0000 000000000000 06-Mar-2023 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 3
0000000 0000000000 21-Feb-2023 00000 00000 0000 Drug Discovery Clinical Trials - General
00000000 000000000 09-Feb-2023 0000 Therapeutic Devices Generating Revenue
00000 000000000000 18-Jan-2023 00000 00000 00000 Drug Discovery Clinical Trials - Phase 1
000000 00000000000 07-Dec-2022 00000 00000 00000 Biotechnology Pre-Clinical Trials
00000 0000 0000000 05-Dec-2022 00000 00000 00000 Drug Discovery Clinical Trials - Phase 1
Immunic Therapeutics 12-Oct-2022 PIPE 0000 Drug Discovery Generating Revenue
Allakos 21-Sep-2022 PIPE 00000 Drug Delivery Generating Revenue
You’re viewing 10 of 97 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RTW Investments Exits (53)

Company Name Exit Date Exit Type Exit Size
ACELYRIN 05-May-2023 IPO 00000
000000000 10-Feb-2023 000 00000
000000 00000000 00 27-Jan-2023 000000000000000000
000000000 000000 26-Jan-2023 0000000 000000 0000
000000000 01-Dec-2022 000000000000000000 0000
00 00000 000000000 22-Aug-2022 000000000000000000 00000
00000000 000000000 06-Apr-2022 0000000 000000 00000
000000 000000 07-Jan-2022 000 00000
Ventyx Biosciences 21-Oct-2021 IPO 00000
Pyxis Oncology 08-Oct-2021 IPO 00000
You’re viewing 10 of 53 exits. Get the full list »

RTW Investments Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

RTW Investments Team (26)

Name Title Deals Funds Boards Office
Robert Aurigema Chief Financial Officer New York, NY
Nathan Pelsma Chief Operating Officer New York, NY
Paul Lu Ph.D Managing Director & Head, Business Development New York, NY
Joshua Kennedy-Smith Ph.D Managing Director & Research Analyst New York, NY
Piratip Pratumsuwan Managing Director & Research Analyst 0 0 New York, NY
You’re viewing 5 of 26 team members. Get the full list »

RTW Investments Co-Investors (248)

Name With Exits Lead Partner Series Industry
Perceptive Advisors 12 0 0 Series chart Industry bar
Cormorant Asset Management 00 0 Series chart Industry bar
RA Capital Management 00 0 Series chart Industry bar
Janus Henderson Investors 00 0 Series chart Industry bar
Logos Capital 0 0 Series chart Industry bar
You’re viewing 5 of 248 co-investors. Get the full list »